Literature DB >> 2319626

Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve.

A C LeBlanc1, J F Poduslo.   

Abstract

The expression of apolipoprotein E (apo E) is dramatically increased following peripheral nerve injury. This increased expression has been postulated to be negatively influenced by unknown mechanisms during subsequent axonal regeneration (Muller et al.: Science 228:499-501, 1985). The present study investigates the role of the regenerating axon in regulating apo E gene expression in two experimental paradigms which permit or prevent axonal regeneration in the adult rat sciatic nerve--the crush or permanent transection injuries. The nerves in these two models undergo axonal degeneration, demyelination, and Schwann cell proliferation; however, subsequent axonal regeneration and remyelination occur only in the distal segment of the crush-injured and not in the permanently transected nerve. The steady-state levels of apo E mRNA in both models increase sharply between 1 and 4 days and reach a maximum level at 12-14 days, which did not change significantly between 14 and 35 days after injury. No significant difference is observed in the steady-state levels of apo E mRNA between the crushed and permanently transected nerves as a function of time after injury. The steady-state protein level of apo E in the endoneurial segments initially increases, peaks at 14-21 days, and then decreases between 35 and 60 days after injury in both models. In contrast, the rate of newly translated and secreted apo E significantly increases by fourfold (P less than 0.005) between 35 and 60 days after permanent transection whereas it does not significantly differ at these times after crush injury. The increased rate of translation and secretion of apo E after transection compared to the constant rate observed after crush injury, together with the comparable steady-state levels of apo E mRNA and protein in both models, suggests translational or post-translational control, but not transcriptional and/or posttranscriptional control, by the regenerating axons. Furthermore, the increasing rate of biosynthesis and secretion of apo E after permanent transection concomitant with the decreasing steady-state levels of the protein suggests that apo E is either removed from the endoneurium or subsequently utilized or degraded by mechanisms that are independent from nerve regeneration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319626     DOI: 10.1002/jnr.490250203

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; María J Bullido; Fernando Valdivieso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Chronic thrombin exposure results in an increase in apolipoprotein-E levels.

Authors:  Molina Mhatre; Kenneth Hensley; Albert Nguyen; Paula Grammas
Journal:  J Neurosci Res       Date:  2006-08-01       Impact factor: 4.164

3.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Age-related binding of proximal region of ApoE promoter to nuclear proteins of mouse cerebral cortex.

Authors:  Sarika Singh; M K Thakur
Journal:  Neurochem Res       Date:  2011-06-05       Impact factor: 3.996

Review 5.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

6.  An Update on Postoperative Cognitive Dysfunction.

Authors:  Tiffany L Tsai; Laura P Sands; Jacqueline M Leung
Journal:  Adv Anesth       Date:  2010

7.  Post-translational modifications of apolipoprotein A-I and Po proteins in the avian peripheral nerve.

Authors:  J Lemieux; S Giannoulis; W C Breckenridge; C Mezei
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

8.  Apolipoprotein E knockout mice have accentuated malnutrition with mucosal disruption and blunted insulin-like growth factor I responses to refeeding.

Authors:  Reinaldo B Oriá; Carlos Meton G Vieira; Relana C Pinkerton; Carlos M de Castro Costa; Maria Beatriz Lopes; Isa Hussaini; Weibin Shi; Gerly A C Brito; Aldo A M Lima; Richard L Guerrant
Journal:  Nutr Res       Date:  2006-08       Impact factor: 3.315

Review 9.  Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.

Authors:  Yadong Huang; Karl H Weisgraber; Lennart Mucke; Robert W Mahley
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains.

Authors:  Arthur C Leuthold; Margaret Y Mahan; John J Stanwyck; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.